Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.019 AUD | +5.56% | -17.39% | -45.71% |
22/05 | Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4% | MT |
20/05 | Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.71% | 10.31M | |
+14.23% | 118B | |
+12.94% | 106B | |
-3.46% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.01% | 15.56B | |
+4.34% | 13.63B | |
+27.59% | 12.27B |
- Stock Market
- Equities
- CHM Stock
- News Chimeric Therapeutics Limited
- Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4%